Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Transcode Therapeutics, Inc.

NASDAQ: RNAZ · Life Sciences · 4 alerts · CIK 1829635

Share price
$1.35Close, Nov 16
Market cap
$23.4M
Shares outstanding
17.3MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Transcode Therapeutics, Inc. filings on SEC EDGAR ↗

4:36 PM ET 8-K
Other 8-K Filing

Transcode Therapeutics Other 8-K Filing

TransCode Therapeutics has initiated a formal strategic process to evaluate alternatives for maximizing the value of its oncology portfolio, including its lead Phase 2a candidate TTX-MC138. The company has engaged Tungsten Advisors to explore potential licensing deals, development partnerships, asset sales, or business combinations.

Counterparty
Tungsten Advisors

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.